Evaluating Snowflake: Insights From 25 Financial Analysts
In the last three months, 25 analysts have published ratings on Snowflake (NYSE:SNOW), offering a diverse range of…
Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock
Ratings for Puma Biotechnology (NASDAQ:PBYI) were provided by 4 analysts in the past three months, showcasing a mix…
The Analyst Landscape: 7 Takes On TScan Therapeutics
Analysts’ ratings for TScan Therapeutics (NASDAQ:TCRX) over the last quarter vary from bullish to bearish, as provided by…
In-Depth Examination Of 10 Analyst Recommendations For Cleanspark
10 analysts have expressed a variety of opinions on Cleanspark (NASDAQ:CLSK) over the past quarter, offering a diverse…
Deep Dive Into Jamf Holding Stock: Analyst Perspectives (10 Ratings)
Ratings for Jamf Holding (NASDAQ:JAMF) were provided by 10 analysts in the past three months, showcasing a mix…
5 Analysts Assess Century Therapeutics: What You Need To Know
Across the recent three months, 5 analysts have shared their insights on Century Therapeutics (NASDAQ:IPSC), expressing a variety…
This Heico Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
Hewlett Packard Enterprise Likely To Report Lower Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
Hewlett Packard Enterprise Company (NYSE:HPE) will release earnings results for its second quarter, after the closing bell on…
Hewlett Packard Trends Bullish Ahead Of Q2 Earnings: AI Servers, High Margin Offerings To Drive Growth
Hewlett Packard is poised to benefit from AI demand; The company's stock is up 19.51% over the past year and 5.71% year-to-date.
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals
Throughout the last three months, 14 analysts have evaluated Regeneron Pharmaceuticals (NASDAQ:REGN), offering a diverse set of opinions…